Glenmark Pharmaceuticals LimitedEigentümerstruktur
| Preis (2025-07-29) | 52W Hoch | 52W Tief |
| 2158 INR | 2.284,8 INR | 1.275,5 INR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - INR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 282.200.992 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Glenmark Pharmaceuticals Limited
Mitarbeiter 0
Handelsplatz NSE
Ticker Symbol GLENMARK
IPO Datum -
Adresse Glenmark House, Mumbai, India, 400099
Webseite https://www.glenmarkpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Glenn Mario Saldanha | Chairman, MD & CEO |
| 2 | Ms. Cherylann Maria Pinto B.Pharm | Executive Director of Corporate Services & Executive Director |
| 3 | Mr. Harish Vinayak Kuber | Company Secretary & Compliance Officer |
| 4 | Mr. Alind Sharma | President and Chief Human Resources Officer |
| 5 | Mr. Ulhas R. Dhuppad | President & Head of Global Pharmaceutical Development |
| 6 | Mr. Indrajit Bose | President & Chief Quality Officer |
| 7 | Mr. Brijlal Motwani | President & Global Head of Formulation Operations |
| 8 | Mr. Alok Malik | President & Business Head of India Formulations |
| 9 | Mr. Christoph Stoller | President and Business Head of Europe & Emerging Markets |
| 10 | Mr. Marc T. Kikuchi B.A., M.B.A. | President & Business Head of North America |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.